Overview
PureCycle’s ground-breaking, patented recycling process, developed and licensed by Procter & Gamble (“P&G”) and commercialized by PureCycle, separates color, odor and other contaminants from plastic waste feedstock to transform it into Ultra-Pure Recycled Polypropylene (“UPRP”) resin with virgin-like properties. The PureCycle process creates an opportunity to fully close the loop in the creation of recycled polypropylene (“rPP”), which, while being one of the highest volume, most versatile and robust plastics, has an extremely low reclamation rate across the globe.
PureCycle holds the possibility to solve for the ongoing problem of recycling the approximately 170 billion pounds of PP produced every year, which has averaged a 5% rate of growth over the last five years. Consumer demand, combined with major multinational sustainability commitments, reinforced by new stringent recycled content restrictions and non-recycled plastic taxes, have led to substantial interest in, and demand for, PureCycle’s UPRP. Today there is virtually no UPRP in the market, and PureCycle is the first company to solely focus on recycling and reintegrating polypropylene upstream into high-value, consumer-facing applications. To date, PureCycle has established strategic partnerships and supply contracts across the plastics value chain including, but not limited to, resin producers, converters, and consumer facing brands.
The PureCycle technology is being brought to market by a strong management team with deep expertise and a demonstrated history of bringing disruptive technologies to market. Over the last three years, PureCycle has built a series of strategic partnerships with major multinational corporations and players in the plastics industry and has memorialized demand commitments through long-term contracts and letters of intent for almost four times (4x) the output of its first production facility in Ironton, Ohio.
PureCycle has been recognized by the American Chemistry Council for its innovation in plastics recycling and, more recently, was recognized by Time Magazine as one of the Top 100 Inventions of the Year in 2019.
Basic Stats
The share price of PureCycle Technologies, Inc. as of September 4, 2025 is $13.16 / share. This is a decrease of -10.05% from the prior week.
The Factor Analysis chart (below right) shows a view of PureCycle Technologies, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 179.84 MM |
| Earnings Date | |
| EPS (TTM) | -1.62 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.53 |
| Short Shares Avail. | 2.80 MM |
| Short Interest | 36.37 MM |
| Short Float | 29.08 % |
| Days to Cover | 18.13 days |
| Risk Free Rate | 4.22 % |
| Price Change (1 yr) | 125.56 % |
| Volatility (1 yr) | 0.96 |
| Beta | 2.67 |
| Sharpe Ratio (1 yr) | 1.26 |
| Sortino Ratio (1 yr) | 3.07 |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | -0.40 |
| ROE | -1.00 |
| ROIC | -0.34 |
| CROIC | 0.32 |
| OCROIC | -0.17 |
| Implied Volatility | 67.27 % |
| Put/Call OI Ratio | 0.52 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for PureCycle Technologies, Inc. is $15.30. The forecasts range from a low of $13.13 to a high of $16.80. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for PureCycle Technologies, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2022-11-11 | Cowen & Co. | Outperform | Maintains | |
| 2022-09-16 | Stifel | Buy | Initiate | |
| 2022-08-15 | Cowen & Co. | Outperform | Maintains | |
| 2021-09-23 | Cowen & Co. | Outperform | Initiate | |
| 2021-08-26 | Jefferies | Buy | Initiate | |
| 2021-04-21 | Roth Capital | Buy | Initiate | |
| 2023-03-17 | Oppenheimer | Outperform | Maintains | |
| 2023-06-21 | Stifel | Buy | Buy | Reiterate |
| 2023-11-09 | Oppenheimer | Outperform | Perform | Downgrade |
| 2023-11-10 | Stifel | Buy | Buy | Maintains |
| 2023-09-14 | Stifel | Buy | Buy | Reiterate |
| 2023-09-14 | Roth MKM | Buy | Buy | Reiterate |
| 2023-12-19 | Roth MKM | Buy | Neutral | Downgrade |
| 2023-08-10 | Oppenheimer | Outperform | Outperform | Maintains |
| 2023-07-14 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-01-03 | Craig-Hallum | Buy | Hold | Downgrade |
| 2024-07-03 | Stifel | Buy | Buy | Reiterate |
| 2024-06-25 | TD Cowen | Buy | Buy | Maintains |
| 2024-08-09 | Craig-Hallum | Hold | Hold | Maintains |
| 2025-06-24 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-11-12 | Stifel | Buy | Buy | Maintains |
| 2024-10-18 | Cantor Fitzgerald | Overweight | Initiate | |
| 2024-08-12 | Stifel | Buy | Buy | Maintains |
| 2024-11-20 | TD Cowen | Buy | Buy | Maintains |
| 2024-11-19 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-08-08 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2025-08-27 | Northland Capital Markets | Outperform | Initiate |
